Kazia Therapeutics KZIA
NASDAQ KZIA
$9.51 +0.04 (+0.42%)
As of: Oct 2, 2026 · 10:06 AM EDT

Kazia Therapeutics (KZIA) Current Deferred Revenue (2017 - 2018)

Updated

Kazia Therapeutics' Current Deferred Revenue was $99,001 in the quarter ended Dec 31, 2018, up 214.0% from $31,531 a year earlier.

Analysis

Kazia Therapeutics (KZIA) Current Deferred Revenue (2017 - 2018) Analysis & Trends

As of Dec 31, 2018, Current Deferred Revenue at Kazia Therapeutics came in at $103,206, up 228.3% from the prior year.

  • In earlier years, Current Deferred Revenue was $31,434 in the year ended Dec 31, 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Kazia Therapeutics 70.77 Mn 70.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 99,000.72
Jun 30, 2018 104,471.09
Dec 31, 2017 31,530.58
Jun 30, 2017 30,799.62
API Access

Kazia Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KZIA&period=max&api_key=YOUR_API_KEY